![Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy | Nature Neuroscience Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy | Nature Neuroscience](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41593-018-0083-7/MediaObjects/41593_2018_83_Fig1_HTML.jpg)
Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy | Nature Neuroscience
![Pathophysiological and diagnostic implications of cortical dysfunction in ALS | Nature Reviews Neurology Pathophysiological and diagnostic implications of cortical dysfunction in ALS | Nature Reviews Neurology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrneurol.2016.140/MediaObjects/41582_2016_Article_BFnrneurol2016140_Fig1_HTML.jpg)
Pathophysiological and diagnostic implications of cortical dysfunction in ALS | Nature Reviews Neurology
![ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS | Neurology ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS | Neurology](https://n.neurology.org/content/neurology/91/15/e1370/F1.large.jpg)
ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS | Neurology
![The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients | Scientific Reports The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-69845-8/MediaObjects/41598_2020_69845_Fig1_HTML.png)
The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients | Scientific Reports
![Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis | Nature Genetics Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis | Nature Genetics](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fng.3622/MediaObjects/41588_2016_Article_BFng3622_Fig1_HTML.jpg)
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis | Nature Genetics
![Petition · Mehr Rechte für & zum Schutz der Tiere, sowie Anerkennung von Hunden als Teil der Familie. · Change.org Petition · Mehr Rechte für & zum Schutz der Tiere, sowie Anerkennung von Hunden als Teil der Familie. · Change.org](https://assets.change.org/photos/2/qg/nw/VLQGNwSHlXZrlOG-800x450-noPad.jpg?1588075434)
Petition · Mehr Rechte für & zum Schutz der Tiere, sowie Anerkennung von Hunden als Teil der Familie. · Change.org
![High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study - EClinicalMedicine High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study - EClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/c70c6ff6-6e0c-4849-a9ec-93b2ad26ce52/gr1.jpg)
High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study - EClinicalMedicine
![Back to Nature Cookies, Non-GMO Double Classic Crème, 10.7 Ounce (Packaging May Vary): Amazon.com: Grocery & Gourmet Food Back to Nature Cookies, Non-GMO Double Classic Crème, 10.7 Ounce (Packaging May Vary): Amazon.com: Grocery & Gourmet Food](https://images-na.ssl-images-amazon.com/images/I/81E98ghJfZL._SX385_.jpg)
Back to Nature Cookies, Non-GMO Double Classic Crème, 10.7 Ounce (Packaging May Vary): Amazon.com: Grocery & Gourmet Food
![Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1 G93A Model | Cell Death & Disease Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1 G93A Model | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-019-1451-2/MediaObjects/41419_2019_1451_Fig1_HTML.png)
Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1 G93A Model | Cell Death & Disease
![Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial - The Lancet Neurology Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2100712422/2079660356/gr1.gif)
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial - The Lancet Neurology
![CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts | Nature Communications CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-017-02643-5/MediaObjects/41467_2017_2643_Fig1_HTML.jpg)